Triazavirin
三氮唑林
Report date: 2022/08/03 20:00:23
NME
Base Information
Drug NameTriazavirin
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesRussian Academy Of SciencesMedsintez
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesWits Health Consortium (Pty) Ltd
Active IndicationsN/A
Inactive Indications